Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2008 Sep 7:3:23.
doi: 10.1186/1748-717X-3-23.

Surgery vs. radiotherapy in localized prostate cancer. Which is best?

Stefan Welz  1 , Maximilian Nyazi, Claus Belka, Ute Ganswindt
Affiliations
Editorial

Surgery vs. radiotherapy in localized prostate cancer. Which is best?

Stefan Welz et al. Radiat Oncol. .

Abstract

Surgery and radiotherapy are currently accepted alternatives for the treatment of localized prostate cancer. In the absence of relevant randomized trials no decision regarding the superiority of any of the given approaches can be made. Up to now several cohort-based approaches indicate similar outcomes for both treatments. Based on a new population based approach, Merglen and co-workers recently concluded that surgery would offer the best chance of long-term control in terms of 10-year survival for T1-T3 prostate cancer patients. Unfortunately the strength of this trial is limited by several shortcomings. Most importantly, issues of radiation dosage have not been taken into account. In addition, several relevant parameters including Gleason score and PSA are not well balanced between the arms and the assignment to arbitrary risk groups does not reflect the real biological behaviour. Thus, the data provided do not support the strong conclusion issued by the authors. Based on the data available, surgery and radiotherapy still have to be considered as equally effective.

PubMed Disclaimer

References

    1. Barry MJ, Albertsen PC, Bagshaw MA, Blute ML, Cox R, Middleton RG, Gleason DF, Zincke H, Bergstralh EJ, Jacobsen SJ. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis. Cancer. 2001;91:2302–14. doi: 10.1002/1097-0142(20010615)91:12<2302::AID-CNCR1262>3.0.CO;2-P. - DOI - PubMed
    1. Merglen A, Schmidlin F, Fioretta G, Verkooijen HM, Rapiti E, Zanetti R, Miralbell R, Bouchardy C. Short- and long-term mortality with localized prostate cancer. Arch Intern Med. 2007;167:1944–50. doi: 10.1001/archinte.167.18.1944. - DOI - PubMed
    1. Newschaffer CJ, Otani K, McDonald MK, Penberthy LT. Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. J Natl Cancer Inst. 2000;92:613–21. doi: 10.1093/jnci/92.8.613. Comment in: J Natl Cancer Inst 2001, 93(5): 397–8. - DOI - PubMed
    1. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology. 2001;58:843–8. doi: 10.1016/S0090-4295(01)01441-8. - DOI - PubMed
    1. Borley N, Fabrin K, Sriprasad S, Mondaini N, Thompson P, Muir G, Poulsen J. Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in "high-risk" prostate cancer compared to MRI or CT. Scand J Urol Nephrol. 2003;37:382–6. doi: 10.1080/00365590310006309. - DOI - PubMed

Publication types